Joëlle Collignon

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Triple-negative breast cancer: treatment challenges and solutions

Guy Jérusalem, Joëlle Collignon, Hélène Schroeder et al. · Breast Cancer Targets and Therapy · 2016 · 383 citations · Full text

Medicine, Oncology, Pharmacology +17

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis

Evandro de Azambuja, Mariana Brandão, Hans Wildiers et al. · ESMO Open · 2020 · 74 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Circulating microRNA-based screening tool for breast cancer

Pierre Frères, Stéphane Wenric, Meriem Boukerroucha et al. · Oncotarget · 2015 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +17